Daniel Anthony Lawton

age ~63

from San Diego, CA

Get Report

Also known as:

Daniel A Lawton
Dan A Lawton
Daniela Lawton

Connected to:

Daniel Lawton Phones & Addresses

San Diego, CA
Austin, TX
Imperial Beach, CA
3953 Sequoia St, San Diego, CA 92109

Work

Position:

Personal Care and Service Occupations

Education

Degree:

High school graduate or higher

License Records

Daniel E Lawton

License #:

34162 - Active

Category:

Tow Truck Operator (Incident Management)

Expiration Date:

Mar 26, 2017

Daniel M Lawton

License #:

3111742 - Expired

Category:

Health Care

Issued Date:

Oct 24, 1996

Effective Date:

Aug 29, 2000

Expiration Date:

Apr 30, 1998

Type:

Registered Nurse

Lawyers & Attorneys

Daniel Anthony Lawton, San Diego CA - Lawyer

view source

Address:

Lawton Law Firm
550 West C Street Suite 1400, San Diego, CA 92101

Licenses:

California - Active 1987

Education:

Georgetown University Law Center
Degree - JD - Juris Doctor - Law
Graduated - 1986
University of Notre Dame
Degree - BA - Bachelor of Arts
Graduated - 1983

Specialties:

Appeals - 25%
Business - 25%
General Practice - 25%
Litigation - 25%

Associations:

Conference of Delegates - Member, 1996-present
Appellate Court Committee - Member, 1993-present
San Diego Education Committee, Litigation Section - Chairman, 1995-1997
American Bar Association - Member
Association of Business Trial Lawyers - Member
State Bar of California - Member

Daniel Joseph Lawton, Austin TX - Lawyer

view source

Address:

Lawton Law Firm
12600 Hill Country Blvd Ste R 275, Austin, TX 78738
512 322-0019 (Office)

Licenses:

Texas - Eligible To Practice In Texas 1994

Education:

Thurgood Marshall School of Law
Degree - Doctor of Jurisprudence/Juris Doctor (J.D.)
Graduated - 1994
Thurgood Marshall School of Law
Degree - Doctor of Jurisprudence/Juris Doctor (J.D.)
Graduated - 1994

Daniel Joseph Lawton, Austin TX - Lawyer

view source

Address:

12113 Roxie Dr, Austin, TX 78729

Phone:

512 257-2010 (Phone)

Experience:

31 years

Jurisdiction:

Texas (1994)

Law School:

Texas Southern University

Education:

Texas Southern University, JD

Memberships:

Texas State Bar (1994)

Daniel Anthony Lawton, San Diego CA - Lawyer

view source

Address:

550 W C St, San Diego, CA 92101

Phone:

619 595-1370 (Phone), 619 595-1520 (Fax)

Experience:

38 years

Specialties:

Business Law

Jurisdiction:

California (1987)

Law School:

Georgetown Univ Law Ctr

Education:

Univ of Notre Dame, Undergraduate Degree
Georgetown Univ Law Ctr, Law Degree

Memberships:

California State Bar (1987)

Us Patents

Substituted N-Acetyl-L-Cysteine Derivatives And Related Compounds
view source
US Patent:

20210395194, Dec 23, 2021
Filed:

Mar 29, 2021
Appl. No.:

17/216285
Inventors:

- Milwaukee WI, US
James Nieman - Sherwood Park, CA
Steven Tanis - Carlsbad CA, US
Daniel Lawton - Bayside WI, US
Garry Smith - Royersford PA, US
Assignee:

Promentis Pharmaceuticals, Inc. - Milwaukee WI
International Classification:

C07C 327/34
C07D 327/04
C07D 241/08
C07C 323/57
C07C 323/60
C07C 323/58
C07C 323/59
C07C 327/32
C07C 329/06
C07D 277/14
C07C 327/26
C07D 277/08
Abstract:

Novel substituted N-acetyl-L-cysteine (NAC) derivatives and related compounds and methods of using these compounds for the treatment of diseases and/or conditions, including but not limited to diseases and/or conditions of, or involving, the Central Nervous System (CNS), including schizophrenia adrenoleukodystrophy, mitochondrial diseases (e.g. Leigh syndrome, Alpers' disease, and MELAS), Huntington's disease, trichotillomania, HIV-associated neurocognitive disorder, hypoxic-ischemic encephalopathy, drug craving, and drug addiction.

Substituted N-Acetyl-L-Cysteine Derivatives And Related Compounds
view source
US Patent:

20190315683, Oct 17, 2019
Filed:

Jun 17, 2019
Appl. No.:

16/443793
Inventors:

- Milwaukee WI, US
James Nieman - Sherwood Park, CA
Steven Tanis - Carlsbad CA, US
Daniel Lawton - Bayside WI, US
Garry Smith - Royersford PA, US
Assignee:

Promentis Pharmaceuticals, Inc. - Milwaukee WI
International Classification:

C07C 327/34
C07C 323/60
C07D 277/14
C07C 327/26
C07D 277/08
C07C 327/32
C07C 329/06
C07C 323/59
C07C 323/58
C07C 323/57
C07D 241/08
C07D 327/04
Abstract:

Novel substituted N-acetyl-L-cysteine (NAC) derivatives and related compounds and methods of using these compounds for the treatment of diseases and/or conditions, including but not limited to diseases and/or conditions of, or involving, the Central Nervous System (CNS), including schizophrenia adrenoleukodystrophy, mitochondrial diseases (e.g. Leigh syndrome, Alpers' disease, and MELAS), Huntington's disease, trichotillomania, HIV-associated neurocognitive disorder, hypoxic-ischemic encephalopathy, drug craving, and drug addiction.

Substituted N-Acetyl-L-Cysteine Derivatives And Related Compounds
view source
US Patent:

20170210716, Jul 27, 2017
Filed:

Apr 7, 2017
Appl. No.:

15/481728
Inventors:

- Milwaukee WI, US
James Nieman - Sherwood Park, CA
Steven Tanis - Carlsbad CA, US
Daniel Lawton - Bayside WI, US
Garry Smith - Royersford PA, US
Assignee:

Promentis Pharmaceuticals, Inc. - Milwaukee WI
International Classification:

C07D 277/08
C07C 323/60
C07C 327/26
C07D 241/08
C07C 329/06
Abstract:

Novel substituted N-acetyl-L-cysteine (NAC) derivatives and related compounds and methods of using these compounds for the treatment of diseases and/or conditions, including but not limited to diseases and/or conditions of, or involving, the Central Nervous System (CNS), including schizophrenia adrenoleukodystrophy, mitochondrial diseases (e.g. Leigh syndrome, Alpers′ disease, and MELAS), Huntington's disease, trichotillomania, HIV-associated neurocognitive disorder, hypoxic-ischemic encephalopathy, drug craving, and drug addiction.

Substituted N-Acetyl-L-Cysteine Derivatives And Related Compounds
view source
US Patent:

20170183303, Jun 29, 2017
Filed:

Mar 15, 2017
Appl. No.:

15/459840
Inventors:

- Milwaukee WI, US
James Nieman - Sherwood Park, CA
Steven Tanis - Carlsbad CA, US
Daniel Lawton - Bayside WI, US
Assignee:

Promentis Pharmaceuticals, Inc. - Milwaukee WI
International Classification:

C07C 327/34
Abstract:

Novel substituted N-acetyl-L-cysteine (NAC) derivatives and related compounds and methods of using these compounds for the treatment of diseases and/or conditions, including but not limited to diseases and/or conditions of, or involving, the Central Nervous System (CNS), including schizophrenia adrenoleukodystrophy, mitochondrial diseases (e.g. Leigh syndrome, Alpers' disease, and MELAS), Huntington's disease, trichotillomania, HIV-associated neurocognitive disorder, hypoxic-ischemic encephalopathy, drug craving, and drug addiction.

Substituted N-Acetyl-L-Cysteine Derivatives And Related Compounds
view source
US Patent:

20150133470, May 14, 2015
Filed:

Nov 7, 2014
Appl. No.:

14/535855
Inventors:

- Milwaukee WI, US
James Nieman - Sherwood Park, CA
Steven Tanis - Carlsbad CA, US
Daniel Lawton - Bayside WI, US
Garry Smith - Royersford PA, US
International Classification:

C07D 277/14
C07D 241/08
C07C 323/58
C07C 323/59
C07C 327/32
C07C 329/06
US Classification:

51425502, 548188, 514369, 558254, 514513, 558248, 514512, 562426, 514562, 544385
Abstract:

Novel substituted N-acetyl-L-cysteine (NAC) derivatives and related compounds and methods of using these compounds for the treatment of diseases and/or conditions, including but not limited to diseases and/or conditions of, or involving, the Central Nervous System (CNS), including schizophrenia adrenoleukodystrophy, mitochondrial diseases (e.g. Leigh syndrome, Alpers' disease, and MELAS), Huntington's disease, trichotillomania, HIV-associated neurocognitive disorder, hypoxic-ischemic encephalopathy, drug craving, and drug addiction.

Ethyl (2R)-2-Acetamido-3-(4-Methylbenzoylsulfanyl)Propanoate And Uses Thereof
view source
US Patent:

20150133544, May 14, 2015
Filed:

Nov 7, 2014
Appl. No.:

14/535953
Inventors:

- Milwaukee WI, US
James Nieman - Sherwood Park, CA
Steven Tanis - Carlsbad CA, US
Daniel Lawton - Bayside WI, US
International Classification:

C07C 327/34
US Classification:

514513, 558254
Abstract:

A novel substituted N-acetyl-L-cysteine (NAC) derivative and methods of using this compound for the treatment of diseases and/or conditions, including but not limited to diseases and/or conditions of, or involving, the Central Nervous System (CNS), including schizophrenia adrenoleukodystrophy, mitochondrial diseases (e.g. Leigh syndrome, Alpers' disease, and MELAS), Huntington's disease, trichotillomania, HIV-associated neurocognitive disorder, hypoxic-ischemic encephalopathy, drug craving, and drug addiction.